Alcon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its +3.0 diopter add power AcrySof® IQ ReSTOR® IOL. This new lens, which was introduced in many major markets outside the United States in early 2008, is now approved in the U.S. for cataract surgery in patients with presbyopia. This lens is another technology advancement for the AcrySof® IQ ReSTOR® platform, which has been the number one choice of surgeons to correct presbyopia in cataract patients since it was introduced in 2005.

Alcon, Inc. has launched its +3.0 Add Power AcrySof® ReSTOR® Aspheric IOL that provides surgeons with another option to meet the clinical needs of their patients. Alcon was given CE Mark for the intraocular lens during late 2007. It is now available in all the major markets apart from the United States. This IOL manages light energy sent to the retina optimally, providing the patients with high resolution image quality and minimal visual disturbances. The clinical studies also showed a high rate of patient satisfaction.